I like a clean number. Here is the one that should anchor your entire decision about immune-support peptides: 31.2. That is the percentage-point gap between treated and untreated patients in the 1998 randomized trial of thymosin alpha-1 in chronic hepatitis…

For healthRX’s compounded semaglutide side effects & safety guide, the useful starting point is not whether the internet is excited about it. It is whether the evidence, safety limits, prescription pathway, and follow-up plan are strong enough to support a…